- Home
- FWONK vs TEVA Comparison
FWONK vs TEVA Comparison
Compare FWONK & TEVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FWONK
- TEVA
- Stock Information
- Founded
- FWONK 1950
- TEVA 1901
- Country
- FWONK United States
- TEVA Israel
- Employees
- FWONK N/A
- TEVA N/A
- Industry
- FWONK Broadcasting
- TEVA Biotechnology: Pharmaceutical Preparations
- Sector
- FWONK Industrials
- TEVA Health Care
- Exchange
- FWONK Nasdaq
- TEVA Nasdaq
- Market Cap
- FWONK 24.9B
- TEVA 21.2B
- IPO Year
- FWONK N/A
- TEVA N/A
- Fundamental
- Price
- FWONK $102.00
- TEVA $23.97
- Analyst Decision
- FWONK Buy
- TEVA Strong Buy
- Analyst Count
- FWONK 9
- TEVA 7
- Target Price
- FWONK $110.56
- TEVA $25.86
- AVG Volume (30 Days)
- FWONK 1.6M
- TEVA 12.1M
- Earning Date
- FWONK 11-05-2025
- TEVA 11-05-2025
- Dividend Yield
- FWONK N/A
- TEVA N/A
- EPS Growth
- FWONK N/A
- TEVA N/A
- EPS
- FWONK 0.85
- TEVA 0.62
- Revenue
- FWONK $4,033,000,000.00
- TEVA $16,776,000,000.00
- Revenue This Year
- FWONK $21.87
- TEVA $4.11
- Revenue Next Year
- FWONK $10.89
- TEVA $0.40
- P/E Ratio
- FWONK $119.81
- TEVA $38.84
- Revenue Growth
- FWONK 8.53
- TEVA 0.02
- 52 Week Low
- FWONK $75.26
- TEVA $12.47
- 52 Week High
- FWONK $109.36
- TEVA $25.00
- Technical
- Relative Strength Index (RSI)
- FWONK 53.71
- TEVA 76.02
- Support Level
- FWONK $97.67
- TEVA $20.11
- Resistance Level
- FWONK $105.41
- TEVA $25.00
- Average True Range (ATR)
- FWONK 3.54
- TEVA 0.70
- MACD
- FWONK 0.68
- TEVA 0.50
- Stochastic Oscillator
- FWONK 68.92
- TEVA 83.00
About FWONK Liberty Media Corporation Series C Liberty Formula One
Liberty Media Corp along with its subsidiaries is engaged in the media and entertainment industries in North America and the United Kingdom. The company owns interests in a high-quality portfolio of assets across the media, entertainment and sports industries. The company derives its maximum revenue from United Kingdom.
About TEVA Teva Pharmaceutical Industries Limited
Teva Pharmaceutical Industries, based in Israel, is the leading generic drug manufacturer in the world. Teva derives half of its sales from North America and makes up a high-single-digit percentage of the total number of generic prescriptions in the US. It also has a significant presence in Europe, Japan, Russia, and Israel. Besides generics, Teva has a portfolio of innovative medicines and biosimilars in three main therapeutic areas: the central nervous system with Copaxone, Ajovy, and Austedo; respiratory with Qvar and ProAir; and oncology with Truxima, Herzuma, and Bendeka/Treanda. Teva also sells active pharmaceutical ingredients, offers contract manufacturing services, and owns Anda, a US-based generic and specialty drug distributor.